Pressure BioSciences, Inc. (PBIO)

Market Cap	15.28M
Revenue (ttm)	1.44M
Net Income (ttm)	-15.50M
Shares Out	12.22M
EPS (ttm)	-2.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,512
Open	1.42
Previous Close	1.39
Day's Range	1.38 - 1.42
52-Week Range	0.91 - 2.40
Beta	0.78
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About PBIO

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. The company also di...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 31, 1996
• Employees: 12
• Stock Exchange: OTCMKTS
• Ticker Symbol: PBIO

Financial Performance

In 2021, PBIO's revenue was $2.00 million, an increase of 64.05% compared to the previous year's $1.22 million. Losses were -$20.15 million, 25.9% more than in 2020.